Vimarsana
Biggest News Aggregation in the World

Page 4 - Session Date News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Session Date. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Session Date Today - Breaking & Trending Today

Tango Therapeutics, Inc. Presents Preclinical Data on Precision Oncology Programs At the American Association of Cancer Research 2023 Annual Meeting - Vimarsana News

Tango Therapeutics, Inc. Presents Preclinical Data on Precision Oncology Programs At the American Association of Cancer Research 2023 Annual Meeting

Tango Therapeutics, Inc. announced highlights from presentations at the American Association for Cancer Research 2023 Annual Meeting, taking place from April 14-19, 2023 in Orlando, Florida. Tango... | April 19, 2023

Viracta Therapeutics Announces Preliminary Dose-Ranging - Vimarsana News

Viracta Therapeutics Announces Preliminary Dose-Ranging

Data from first two dose levels of Nana-val in patients with EBV+ recurrent/metastatic nasopharyngeal carcinoma support continued dose escalation to...

Epygenix Therapeutics to Present at the American Epilepsy Society 2022 Annual Meeting in Nashville - Vimarsana News

Epygenix Therapeutics to Present at the American Epilepsy Society 2022 Annual Meeting in Nashville

Epygenix Therapeutics, a clinical-stage biopharmaceutical company focused on discovering and developing therapies for rare and intractable forms of genetic

Oncolytics Biotech® Reports Interim Results from Phase 1/2 GOBLET Study Showing a 70% Objective Response Rate in Pancreatic Cancer at the SITC Annual Meeting - Vimarsana News

Oncolytics Biotech® Reports Interim Results from Phase 1/2 GOBLET Study Showing a 70% Objective Response Rate in Pancreatic Cancer at the SITC Annual Meeting

70% objective response rate (ORR; n=10) is nearly triple the average ORR of ~25% reported in historical control trials1-4 Data suggest pelareorep synergizes...

Rain Therapeutics Announces a Poster Presentation at the - Vimarsana News

Rain Therapeutics Announces a Poster Presentation at the

NEWARK, Calif., Oct. 26, 2022 (GLOBE NEWSWIRE) -- Rain Therapeutics Inc. (NasdaqGS: RAIN), (“Rain”), a late-stage company developing precision oncology...